U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool Qualification Programs
  5. DDT COA #000036: Impact of Weight on Quality of Life- Lite (IWQOL-Lite) Clinical Trials Version
  1. Development & Approval Process | Drugs

DDT COA #000036: Impact of Weight on Quality of Life- Lite (IWQOL-Lite) Clinical Trials Version

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Drug Evaluation (ODE) II
Division of Metabolism and Endocrinology Products (DMEP)

DDT COA Number
DDT COA #000036

Instrument Name
Impact of Weight on Quality of Life- Lite (IWQOL-Lite) Clinical Trials Version

Disease/Condition
Obesity

Concept of Interest
weight-related quality of life concepts

Context of Use

  • Obese adults with no weight-related comorbidities and
  • Overweight and obese adults with >1 weight-related comorbidity

COA Type
PRO

Qualification Stage
In transition to 507 process 

Requestor(s)
Quality of Life Consulting & Duke University Medical Center

Contact(s)
Ronette Kolotkin

Date Accepted into CDER’s COA Qualification Program
April 19, 2013

Back to Clinical Outcome Assessments (COA) Qualification Submission